0001628280-24-050104.txt : 20241205
0001628280-24-050104.hdr.sgml : 20241205
20241205170235
ACCESSION NUMBER: 0001628280-24-050104
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20241101
FILED AS OF DATE: 20241205
DATE AS OF CHANGE: 20241205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krogulski Kenneth
CENTRAL INDEX KEY: 0001695580
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33637
FILM NUMBER: 241529809
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE, SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001087294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE,
STATE: TN
ZIP: 37203
BUSINESS PHONE: 615-255-0068
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4
1
wk-form4_1733436149.xml
FORM 4
X0508
4
2024-11-01
0
0001087294
CUMBERLAND PHARMACEUTICALS INC
CPIX
0001695580
Krogulski Kenneth
1600 WEST END AVE., SUITE 1300
NASHVILLE
TN
37203
1
0
0
0
1
Common Stock
2024-11-01
5
P
0
E
380
1.15
A
263978
D
Common Stock
2024-11-04
5
P
0
E
245
1.17
A
264223
D
Common Stock
2024-11-05
5
P
0
E
380
1.20
A
264603
D
Common Stock
2024-11-06
5
P
0
E
380
1.20
A
264983
D
Common Stock
2024-11-07
5
P
0
E
380
1.17
A
265363
D
Common Stock
2024-11-08
5
P
0
E
380
1.18
A
265743
D
Common Stock
2024-11-11
5
P
0
E
380
1.20
A
266123
D
Common Stock
2024-11-12
5
P
0
E
380
1.20
A
266503
D
Common Stock
2024-11-13
5
P
0
E
380
1.20
A
266883
D
Common Stock
2024-11-14
5
P
0
E
380
1.19
A
267263
D
Common Stock
2024-11-15
5
P
0
E
380
1.17
A
267643
D
Common Stock
2024-11-18
5
P
0
E
380
1.18
A
268023
D
Common Stock
2024-11-19
5
P
0
E
380
1.15
A
268403
D
Common Stock
2024-11-20
5
P
0
E
427
1.13
A
268830
D
Common Stock
2024-11-21
5
P
0
E
427
1.09
A
269257
D
Common Stock
2024-11-22
5
P
0
E
474
1.07
A
269731
D
Common Stock
2024-11-25
5
P
0
E
474
1.09
A
270205
D
Common Stock
2024-11-26
5
P
0
E
474
1.11
A
270679
D
Common Stock
2024-11-27
5
P
0
E
474
1.15
A
271153
D
Common Stock
2024-11-29
5
P
0
E
474
1.32
A
271627
D
The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.
Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
2024-12-05